BioScrip, Inc. (NASDAQ:BIOS)
The Company provides pharmaceutical and pharmacy benefit management services.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
rocknpopstocks
(< 20)
Submitted: 1/20/2011 12:02:13 PM :
Start Price:
$5.01
BIOS Score:
+28.98
Should see strong play as the market picks back up.
Recs
21popsontop
(< 20)
Submitted: 12/1/2010 1:43:18 PM :
Start Price:
$4.48
BIOS Score:
+39.22
Longshots under $5 screen.
Recs
franktejon
(< 20)
Submitted: 11/3/2010 6:03:48 AM :
Start Price:
$4.49
BIOS Score:
+37.55
strong buy at $2.00
Recs
dynam000
(< 20)
Submitted: 9/22/2010 1:49:00 PM :
Start Price:
$5.27
BIOS Score:
+9.18
CHS acquisition to assist with revenue and earnings growth. Fairly priced today, but has potential to outperform once all acquisition operational issues are resolved.
Recs
ibitegirls
(< 20)
Submitted: 7/31/2010 11:26:37 PM :
Start Price:
$4.55
BIOS Score:
+27.83
oversold and shows up on my voodoo magic formula of world domination screener
Recs
HealthcareGuy
(98.11)
Submitted: 4/6/2010 4:51:12 PM :
Start Price:
$9.37
BIOS Score:
-41.57
Home Infusion = great biz models, large players like BIOS will be always get taken out
Recs
cbierbaum
(65.58)
Submitted: 11/4/2009 8:50:47 PM :
Start Price:
$7.72
BIOS Score:
-40.30
BIOS has begun to cut necessary overhead reaching critical mass and positive operating leverage. According to an analysis conducted by Kaiser Permanente most payors contract with more than one specialty pharmacy management company and view cost containment in this space a priority. This should allow for ample opportunities to gain market share from leaders ESRX, MHS and ABC. With a strong biologic pipeline with many drugs competing in the same care class, the need for specialty pharmacy, DM, PBM and distributions services is set to be robust for the foreseeable future. Given that Part B is largely unaffected by healthcare reform proposals, I believe that an increase in covered lives and underlying secular trends for biotherapeutics will allow BIOS to outperform the market for some time to come. When evaluating precedent transactions, both public and private, in the specialty pharmacy/distribution space, and backing into an intrinsic EV/EBITDA multiple, I find that BIOS, now that operating and management issues are being smoothed out, has the potential to trade between 18-21x forward EBITDA.
Recs
TheDoughMaker
(57.95)
Submitted: 6/11/2009 10:51:20 AM :
Start Price:
$4.45
BIOS Score:
+7.49
Excellent Takeover Candidate!
Recs
LawfordCap
(99.94)
Submitted: 5/5/2009 3:45:02 PM :
Start Price:
$3.37
BIOS Score:
+49.71
trend PS test
Recs
golfer03
(< 20)
Submitted: 1/13/2009 10:16:35 PM :
Start Price:
$2.84
BIOS Score:
+77.09
With upcoming changes with our Health System puts BIOS in the Catbird seat going forward…
Recs
killianxplay
(< 20)
Submitted: 9/10/2008 5:49:48 PM :
Start Price:
$2.75
BIOS Score:
+131.41
under rated
Recs
biovestor
(< 20)
Submitted: 6/28/2008 6:28:04 AM :
Start Price:
$2.69
BIOS Score:
+142.07
A specialty small/micro-cap pharmacy benefit manager in an industry group that is currently out of favor, but likely to rebound strongly or be acquired over the next year or so.
Recs
evillate
(< 20)
Submitted: 6/20/2008 10:40:35 PM :
Start Price:
$3.28
BIOS Score:
+100.36
Will double my money with this EASY.
Recs
MFClobberMeSilly
(73.19)
Submitted: 11/14/2007 1:47:28 PM :
Start Price:
$9.35
BIOS Score:
-22.99
9.43 100% return in 2 years
Recs
oystermighty
(< 20)
Submitted: 10/30/2007 3:41:43 PM :
Start Price:
$8.12
BIOS Score:
-9.26
Excellent trend
Recs
mlkr
(41.01)
Submitted: 9/12/2007 12:10:45 AM :
Start Price:
$6.51
BIOS Score:
+7.22
On move.. Good investment/traading stock..
Recs
GaTeek
(< 20)
Submitted: 5/3/2007 6:56:03 PM :
Start Price:
$3.51
BIOS Score:
+96.85
Compare to major PBM performance, margins back during MIMS deal, post restructuring moves by management
Recs
pekl06a
(< 20)
Submitted: 1/21/2007 4:51:04 PM :
Start Price:
$3.74
BIOS Score:
+79.61
undervalued medical play, with growth. Buyout possibility, or merge with Option Care(OPTN)
Recs
StingyDog
(< 20)
Submitted: 1/19/2007 6:18:02 PM :
Start Price:
$3.74
BIOS Score:
+79.61
0.7 Price/Book
Recs
printpuppy
(< 20)
Submitted: 1/17/2007 12:58:56 PM :
Start Price:
$3.79
BIOS Score:
-77.46
Sales force is gone, CAP (medicare) program is disaster (company is only provider only because no one else wanted it), management has put golden parachutes in place.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 20